ClinicalTrials.Veeva

Menu

Impact of Hepatitis B Virus on Inflammatory Bowel Disease

T

Tanta University

Status

Enrolling

Conditions

Hepatitis B Virus
Inflammatory Bowel Disease (IBD)

Treatments

Other: History of IBD course and outcome in HBV patients

Study type

Observational

Funder types

Other

Identifiers

NCT06881238
36264PR979/12/24

Details and patient eligibility

About

The goal of this observational retrospective study is to assess the impact of hepatitis B virus (HBV) infection on the clinical course and outcomes of inflammatory bowel disease (IBD) in Egyptian patients.

Researchers will compare the IBD extent, location, severity, and behavior between IBD patients with and without HBV infection.

Participants will be subjected to history-taking (history of hospital admission and disease flare, surgical history, medication history, follow-up duration, and mortality), clinical examination, laboratory investigations, abdominal ultrasonography, and endoscopic examination.

Enrollment

162 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Male or female patients older than 18 years.
  • Patients with IBD are diagnosed by clinical, radiological, endoscopic, and histological criteria.

Exclusion criteria

  • Patients aged < 18 years
  • Unwilling to participate in our study

Trial design

162 participants in 2 patient groups

IBD patients with positive HBV infection.
Description:
81 IBD patients with positive HBV infection.
Treatment:
Other: History of IBD course and outcome in HBV patients
IBD Patients with negative HBV infection
Description:
81 IBD Patients with negative HBV infection
Treatment:
Other: History of IBD course and outcome in HBV patients

Trial contacts and locations

1

Loading...

Central trial contact

Nabila A Elgazzar, MD; Rania M Elkafoury, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems